| human | Q5 |
| P12541 | Ludzie Nauki ID (new) | kLyXe8QJeTa |
| P7293 | National Library of Poland Descriptor | 9810533085505606 |
| P496 | ORCID iD | 0000-0001-9300-4833 |
| 0000-0002-0202-5987 | ||
| P3124 | Polish scientist ID | 254758 |
| P214 | VIAF cluster ID | 313523944 |
| P512 | academic degree | habilitation | Q308678 |
| P27 | country of citizenship | Poland | Q36 |
| P108 | employer | Medical College of Jagiellonian University | Q6122616 |
| P734 | family name | Musiałek | Q110268958 |
| P735 | given name | Piotr | Q15897269 |
| Piotr | Q15897269 | ||
| P1412 | languages spoken, written or signed | Polish | Q809 |
| P1559 | name in native language | Piotr Musiałek | |
| P103 | native language | Polish | Q809 |
| P106 | occupation | researcher | Q1650915 |
| cardiologist | Q3264451 | ||
| P21 | sex or gender | male | Q6581097 |
| Q51801268 | A Prospective, Multicenter Study of a Novel Mesh-Covered Carotid Stent: The CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). |
| Q86197455 | Aspirin resistance in adult patients after Fontan surgery |
| Q51216979 | Assessment of flow changes in the circle of Willis after stenting for severe internal carotid artery stenosis. |
| Q37738591 | Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial |
| Q51190883 | Carotid artery stenting according to the "tailored CAS" algorithm performed in the very elderly patients: the thirty day outcome. |
| Q34243299 | Carotid artery stenting according to the tailored-CAS algorithm is associated with a low complication rate at 30 days: data from the TARGET-CAS study |
| Q45006477 | Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS). |
| Q46352103 | Carotid intima-media thickness in pre- and postmenopausal women with suspected coronary artery disease. |
| Q51139784 | Commentary: Carotid Artery Revascularization for Stroke Prevention: A New Era. |
| Q91860522 | Commentary: Double-Layer Carotid Stents: From the Clinical Need, through a Stent-in-Stent Strategy, to Effective Plaque Isolation… the Journey Toward Safe Carotid Revascularization Using the Endovascular Route |
| Q53254910 | Commentary: vertebral artery ostial stenosis stenting technique: the concept reversed? |
| Q38610604 | Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications. |
| Q35115144 | Coronary microcirculation and reperfusion failure. Do we know what diagnostic tools we have? |
| Q80431149 | Detection of microvascular injury by evaluating epicardial blood flow in early reperfusion following primary angioplasty |
| Q51244588 | Determinants of immediate and long-term results of subclavian and innominate artery angioplasty |
| Q88859863 | Determinants of long-term outcome in patients after percutaneous stent-assisted management of symptomatic subclavian or innominate artery stenosis or occlusion |
| Q80109845 | Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis |
| Q51015277 | Doppler ultrasonography in suspected subclavian artery obstruction and in patient monitoring after subclavian stenting. |
| Q49683839 | Drug action(s), drug marketing, and clinical medicine. Suppression of ventricular arrhythmogenicity with If blockade in human heart failure: emerging clinical evidence for ivabradine treatment benefit beyond heart rate control |
| Q81747722 | Early myocardial engraftment of autologous CD34+ cells administered transcoronary via a physiological cell-delivery system |
| Q81450255 | Evaluation of cerebral circulation in patients with significant carotid artery stenosis |
| Q83828198 | Fibrinogen and carotid intima media thickness determine fibrin density in different atherosclerosis extents |
| Q48385139 | Flow reversal for proximal neuroprotection during endovascular management of critical symptomatic carotid artery stenosis coexisting with ipsilateral external carotid artery occlusion. |
| Q81410531 | Gender differences in carotid intima-media thickness in patients with suspected coronary artery disease |
| Q50185155 | Giant pericardial cyst compressing the right ventricle |
| Q64111879 | Highly-calcific carotid lesions endovascular management in symptomatic and increased-stroke-risk asymptomatic patients using the CGuard™ dual-layer carotid stent system: Analysis from the PARADIGM study |
| Q49383488 | How asymptomatic is "asymptomatic" carotid stenosis? Resolving fundamental confusion(s) - and confusions yet to be resolved. |
| Q85070484 | How should I treat a very large thrombus burden in the infarct-related artery in a young patient with an unexplained lower GI tract bleeding? |
| Q55021794 | Hybrid one-day coronary artery bypass grafting and carotid artery stenting - cardiac surgeons' perspective on the procedure's safety. |
| Q38125953 | If current inhibition and mortality reduction in heart failure: more than just a 'pure' effect of lowering heart rate |
| Q80078775 | Incidence of ischemic mitral regurgitation in 1155 consecutive acute myocardial infarction patients treated with primary or facilitated angioplasty |
| Q47264225 | Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging |
| Q61942700 | Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int |
| Q55374949 | Ischemic Versus Non-Ischemic (Neurogenic) Myocardial Contractility Impairment in Acute Coronary Syndromes: Prevalence and Impact on Left Ventricular Systolic Function Recovery. |
| Q90923957 | Letter by Mazurek et al Regarding Article, "Short-Term Double Layer Mesh Stent Patency for Emergent or Elective Carotid Artery Stenting: A Single Center Experience". |
| Q50174509 | Letter by Musialek et al Regarding Article, "Acute Occlusions of Dual-Layer Carotid Stents After Endovascular Emergency Treatment of Tandem Lesions". |
| Q46014540 | Magnetic resonance imaging and clinical outcome in patients with symptomatic carotid artery stenosis after carotid artery revascularization. |
| Q98728533 | Mechanical thrombectomy for ischemic stroke: Poland-time to move on! Authors' reply |
| Q35876556 | Mobilization of CD34+CXCR4+ stem/progenitor cells and the parameters of left ventricular function and remodeling in 1-year follow-up of patients with acute myocardial infarction |
| Q37043341 | Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis |
| Q35829154 | Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. |
| Q59577685 | Nitric oxide and cardiac pacemaking |
| Q35084075 | Nitric oxide stimulation of cardiac pacemaking in the sino-atrial node through the activation of a novel signalling pathway: overview of in vitro and in vivo evidence for a new basic mechanism in the control of heart rate. |
| Q39765369 | Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent sy |
| Q38629473 | One swallow does not a summer make but many swallows do: accumulating clinical evidence for nearly-eliminated peri-procedural and 30-day complications with mesh-covered stents transforms the carotid revascularisation field |
| Q90203871 | One-day, sequential carotid artery stenting followed by cardiac surgery in patients with severe carotid and cardiac disease |
| Q92556911 | Percutaneous management of long and diffused coronary lesions using newer generation drug-eluting stents in routine clinical practice: long-term outcomes and complication predictors |
| Q43270410 | Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease |
| Q84647370 | Predictors of cerebral reperfusion injury after carotid stenting: the role of transcranial color-coded Doppler ultrasonography |
| Q46956869 | Prevalence and prediction of renal artery stenosis in patients with coronary and supraaortic artery atherosclerotic disease |
| Q83382350 | Progressive bradycardia with increasing doses of dobutamine leading to stress echo interruption |
| Q48490165 | Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting |
| Q92861432 | Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year-Hybrid coronary REvascularization Versus Stenting or Surgery ( |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q35745566 | Relationship between mitral leaflets angles, left ventricular geometry and mitral deformation indices in patients with ischemic mitral regurgitation: imaging by echocardiography and cardiac magnetic resonance |
| Q89692202 | Residual plaque prolapse with novel dual-layer carotid stents: is it mesh-covered or not? |
| Q33167638 | Resolution of ischemic symptoms after percutaneous angioplasty for a symptomatic subclavian artery stenosis. |
| Q84124640 | Restenosis after carotid artery stenting versus endarterectomy: the jury is still out! |
| Q45277661 | Right ventricular infarction: novel modalities of treatment |
| Q96123531 | Routine MicroNET-covered embolic prevention stent system use for consecutive symptomatic and increased stroke-risk asymptomatic carotid stenosis revascularization : Twelve-month outcomes from the PARADIGM study |
| Q30455282 | Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesions |
| Q92616648 | Severe, recurrent in-stent carotid restenosis: endovascular approach, risk factors. Results from a prospective academic registry of 2637 consecutive carotid artery stenting procedures (TARGET-CAS) |
| Q100544468 | Simple clinical scores to predict blood pressure and renal function response to renal artery stenting for atherosclerotic renal artery stenosis |
| Q59391814 | Stress in adults with congenital heart disease – preliminary results on anxiety, life events, coping and socioeconomic factors (RCD code: IV) |
| Q43270409 | Supra-aortic extracranial artery atherosclerotic lesions in patients diagnosed for coronary artery disease: prevalence and predictors |
| Q45037457 | TASTE-less endpoint of 30-day mortality (and some other issues with TASTE) in evaluating the effectiveness of thrombus aspiration in STEMI: not the "evidence" to change the current practice of routine consideration of manual thrombus extraction |
| Q57301701 | Temporal changes in the pattern of invasive angiography use and its outcome in suspected coronary artery disease: implications for patient management and healthcare resources utilization |
| Q92115819 | The Cardiovascular Research community calls for action to address the growing burden of cardiovascular disease |
| Q54770977 | The Virtual histology In CaroTids Observational RegistrY (VICTORY) study: a European prospective registry to assess the feasibility and safety of intravascular ultrasound and virtual histology during carotid interventions. |
| Q90941126 | The cardio-vascular future of panvascular medicine: the basics |
| Q84569526 | The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis |
| Q82974305 | The use of a novel type of distal protection system (FiberNet®) in the percutaneous management of saphenous vein graft disease |
| Q83921613 | Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial in |
| Q36516672 | Treatment strategies in severe symptomatic carotid and coronary artery disease |
| Q88880897 | Ultrasound‑assisted, catheter‑directed, low‑dose thrombolysis for the treatment of acute intermediate‑high risk pulmonary embolism |
| Q97680492 | Use of Dual-Layered Stents for Carotid Artery Angioplasty: 1-Year Results of a Patient-Based Meta-Analysis |
| Q90313815 | Use of Dual-Layered Stents in Endovascular Treatment of Extracranial Stenosis of the Internal Carotid Artery: Results of a Patient-Based Meta-Analysis of 4 Clinical Studies |
| Q80424678 | Use of the Parodi Anti-Emboli System and transient subclavian steal for cerebral protection during emergent vertebral artery recanalization |
| Q45923776 | Virtual histology intravascular ultrasound evaluation of atherosclerotic carotid artery stenosis: time for fully quantitative image analysis |
| Q93234820 | Where and how to treat a man presenting up to 4 hours after cerebral large-vessel occlusion to a thrombectomy-capable major regional hospital |
| Q84567164 | Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population |
| Q84361059 | [Carotid artery stenting with proximal or distal brain protection: early outcome] |
| Q80174736 | [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up] |
| Q82591293 | [Subintimal recanalisation of chronic superficial femoral artery occlusion with the use of a re-entry system] |
| Q80676593 | [Visualisation of early engraftment of transcoronary applied CD34+ cells in the infarct border zone] |
Search more.